Log in to save to my catalogue

Neurocognitive and hypokinetic movement disorder with features of parkinsonism following BCMA-target...

Neurocognitive and hypokinetic movement disorder with features of parkinsonism following BCMA-target...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8678323

Neurocognitive and hypokinetic movement disorder with features of parkinsonism following BCMA-targeting CAR-T cell therapy

About this item

Full title

Neurocognitive and hypokinetic movement disorder with features of parkinsonism following BCMA-targeting CAR-T cell therapy

Journal title

Nature medicine, 2021-12, Vol.27 (12), p.2099-2103

Language

English

Formats

More information

Scope and Contents

Contents

B-cell maturation antigen (BCMA) is a prominent tumor-associated target for chimeric antigen receptor (CAR)-T cell therapy in multiple myeloma (MM). We describe the case of a MM patient, enrolled in the CARTITUDE-1 trial (
NCT03548207
), who developed a progressive movement disorder with features of parkinsonism approximately three months aft...

Alternative Titles

Full title

Neurocognitive and hypokinetic movement disorder with features of parkinsonism following BCMA-targeting CAR-T cell therapy

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8678323

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8678323

Other Identifiers

ISSN

1078-8956

E-ISSN

1546-170X

DOI

10.1038/s41591-021-01564-7

How to access this item